Synthesis of methotrexate-dimyristoylphosphatidylethanolamine analogs and characterization of methotrexate release in vitro

No abstract is available for this paper.

• Publication year

  1992

• Venue

  International Journal of Pharmaceutics

• Publication date

  1992-09-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0378-5173(92)90148-U
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Complications of immunosuppression associated with weekly low dose methotrexate.

  1991cited by this paper
• Affinity labeling of folate transport proteins with the N-hydroxysuccinimide ester of the gamma-isomer of fluorescein-methotrexate.

  1991cited by this paper
• Synthesis and in vitro biological activity of new deaza analogues of folic acid, aminopterin, and methotrexate with an L-ornithine side chain.

  1991cited by this paper
• Radiologic progression during intramuscular methotrexate treatment of rheumatoid arthritis.

  1990cited by this paper
• Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis.

  1990cited by this paper
• Pharmacokinetics of methotrexate administered by intramuscular and subcutaneous injections in patients with rheumatoid arthritis.

  1990cited by this paper
• Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis.

  1990cited by this paper
• Methotrexate pharmacokinetics in patients with rheumatoid arthritis.

  1989cited by this paper
• Inhibition of cell proliferation with antibody-targeted liposomes containing methotrexate-γ-dimyristoylphosphatidylethanolamine

  1988cited by this paper
• Inflammatory joint disease: a comparison of liposome scanning, bone scanning, and radiography.

  1988cited by this paper
• Retention and Distribution of Liposome‐entrapped [3H]Methotrexate Injected into Normal or Arthritic Rabbit Joints

  1988cited by this paper
• Methotrexate in rheumatoid arthritis.

  1988cited by this paper
• Synovial accumulation of technetium labelled liposomes in rheumatoid arthritis.

  1987cited by this paper
• Inhibition of cell proliferation by putative metabolites and non-degradable analogs of methotrexate-Y-dimyristoylphosphatidylethanolamine

  1987cited by this paper
• Imaging in rheumatoid arthritis using liposomes labelled with technetium.

  1986cited by this paper
• The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis.

  1986cited by this paper
• Methotrexate analogues. 28. Synthesis and biological evaluation of new gamma-monoamides of aminopterin and methotrexate.

  1986cited by this paper
• Inhibition of cell proliferation and dihydrofolate reductase by liposomes containing methotrexate-dimyristoylphosphatidylethanolamine derivatives and by the glycerophosphorylethanolamine analogs.

  1985cited by this paper
• Synthesis and characterization of methotrexate-dimyristoylphosphatidylethanolamine derivatives and the glycerophosphorylethanolamine analogs.

  1985cited by this paper
• Role of subcellular organelles: lysosomes

  1985cited by this paper
• Methotrexate analogues. 16. Importance of the side-chain amide carbonyl group as a structural determinant of biological activity.

  1982cited by this paper
• Colorimetric determination of phospholipids with ammonium ferrothiocyanate.

  1980cited by this paper
• Methotrexate analogues. 10. Direct coupling of methotrexate and diethyl L-glutamate in the presence of peptide bond-forming reagents.

  1978cited by this paper
• Synthesis of a fluorescent derivative of amethopterin,.

  1975cited by this paper
• Determination of lipid phosphorus in the nanomolar range.

  1970cited by this paper

• Bio-responsive self-assembled nanoparticles of fatty acid prodrugs of sulfapyridine for the management of Rheumatoid arthritis.

  2026cites this paper
• Preparation and Evaluation of 64Cu-Radiolabled Dual-Ligand Multifunctional Gold Nanoparticles for Tumor Theragnosis

  2023cites this paper
• Fail-safe nano-formulation of prodrug of sulfapyridine: Preparation and evaluation for treatment of rheumatoid arthritis.

  2021cites this paper
• The influence of carbohydrate ligands on the cytotoxicity of liposomes bearing a methotrexate-diglyceride conjugate in human acute leukemia cell cultures

  2009cites this paper
• Synthesis of a novel phosphatidylcholine conjugated to docosahexaenoic acid and methotrexate that inhibits cell proliferation

  2002cites this paper
• Tris Lipidation: A Chemically Flexible Technology For Modifying The Delivery Of Drugs and Genes

  2000cites this paper
• The suppression of rat collagen-induced arthritis and inhibition of macrophage derived mediator release by liposomal methotrexate formulations

  2000cites this paper
• Tris and the ready production of drug‐fatty acyl conjugates

  1999cites this paper
• Interleukin‐1β (IL‐1β) inhibition: a possible mechanism for the anti‐inflammatory potency of liposomally conjugated methotrexate formulations in arthritis

  1999cites this paper
• Lipophilic drug derivatives in liposomes

  1998cites this paper
• A single intra-articular injection of liposomally conjugated methotrexate suppresses joint inflammation in rat antigen-induced arthritis.

  1996cites this paper
• Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant‐induced arthritis

  1995cites this paper
• Prostaglandin and tumor necrosis factor secretion by peritoneal macrophages isolated from normal and arthritic rats treated with liposomal methotrexate.

  1994cites this paper
• Effect of Three Lipophilic Methotrexate Derivatives Upon Mediator Release by Lipopolysaccharide‐stimulated Rat Peritoneal Macrophages

  1994cites this paper
• Effect of liposomally encapsulated MTX-DMPE conjugates upon TNF alpha and PGE2 release by lipopolysaccharide stimulated rat peritoneal macrophages.

  1994cites this paper